200 related articles for article (PubMed ID: 19889947)
1. Analysis of recombinant human semenogelin as an inhibitor of human sperm motility.
Mitra A; Richardson RT; O'Rand MG
Biol Reprod; 2010 Mar; 82(3):489-96. PubMed ID: 19889947
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human sperm motility by contraceptive anti-eppin antibodies from infertile male monkeys: effect on cyclic adenosine monophosphate.
O'Rand MG; Widgren EE; Beyler S; Richardson RT
Biol Reprod; 2009 Feb; 80(2):279-85. PubMed ID: 18945989
[TBL] [Abstract][Full Text] [Related]
3. Interacting proteins on human spermatozoa: adaptive evolution of the binding of semenogelin I to EPPIN.
Silva EJ; Hamil KG; O'Rand MG
PLoS One; 2013; 8(12):e82014. PubMed ID: 24312623
[TBL] [Abstract][Full Text] [Related]
4. Epididymal protein targets: a brief history of the development of epididymal protease inhibitor as a contraceptive.
O'Rand MG; Widgren EE; Hamil KG; Silva EJ; Richardson RT
J Androl; 2011; 32(6):698-704. PubMed ID: 21441428
[TBL] [Abstract][Full Text] [Related]
5. Loss of calcium in human spermatozoa via EPPIN, the semenogelin receptor.
O'Rand MG; Widgren EE
Biol Reprod; 2012 Feb; 86(2):55. PubMed ID: 22075473
[TBL] [Abstract][Full Text] [Related]
6. Functional studies of eppin.
O'Rand MG; Widgren EE; Hamil KG; Silva EJ; Richardson RT
Biochem Soc Trans; 2011 Oct; 39(5):1447-9. PubMed ID: 21936831
[TBL] [Abstract][Full Text] [Related]
7. Characterization of EPPIN's semenogelin I binding site: a contraceptive drug target.
Silva EJ; Hamil KG; Richardson RT; O'Rand MG
Biol Reprod; 2012 Sep; 87(3):56. PubMed ID: 22699487
[TBL] [Abstract][Full Text] [Related]
8. Association of eppin with semenogelin on human spermatozoa.
Wang Z; Widgren EE; Sivashanmugam P; O'Rand MG; Richardson RT
Biol Reprod; 2005 May; 72(5):1064-70. PubMed ID: 15590901
[TBL] [Abstract][Full Text] [Related]
9. Dissecting EPPIN protease inhibitor domains in sperm motility and fertilizing ability: repercussions for male contraceptive development.
Silva AAS; Raimundo TRF; Mariani NAP; Kushima H; Avellar MCW; Buffone MG; Paula-Lopes FF; Moura MT; Silva EJR
Mol Hum Reprod; 2021 Nov; 27(12):. PubMed ID: 34792600
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition activity of semenogelin and its peptides to human spermatozoa].
Wang ZJ; Zhang W; Wu HF; Xu YG
Zhonghua Nan Ke Xue; 2007 Jan; 13(1):42-5. PubMed ID: 17302034
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an eppin protein complex from human semen and spermatozoa.
Wang Z; Widgren EE; Richardson RT; O'Rand MG
Biol Reprod; 2007 Sep; 77(3):476-84. PubMed ID: 17567961
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: identity with semenogelin.
Robert M; Gagnon C
Biol Reprod; 1996 Oct; 55(4):813-21. PubMed ID: 8879494
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of epididymal protease inhibitor modulating the liquefaction of human semen.
Wang ZJ; Zhang W; Feng NH; Song NH; Wu HF; Sui YG
Asian J Androl; 2008 Sep; 10(5):770-5. PubMed ID: 18645681
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of epididymal protease inhibitor Eppin and Semenogelin on human ejaculated spermatozoa].
Wang ZJ; Wu HF; Qian LX; Qiao D; Shao JF; Zhang W; Sui YG; Xu ZQ
Zhonghua Nan Ke Xue; 2006 May; 12(5):428-31, 434. PubMed ID: 16755874
[TBL] [Abstract][Full Text] [Related]
15. Epididymal protease inhibitor (EPPIN) is differentially expressed in the male rat reproductive tract and immunolocalized in maturing spermatozoa.
Silva EJ; PatrĂ£o MT; Tsuruta JK; O'Rand MG; Avellar MC
Mol Reprod Dev; 2012 Dec; 79(12):832-42. PubMed ID: 23070980
[TBL] [Abstract][Full Text] [Related]
16. Human Semenogelin 1 Promotes Sperm Survival in the Mouse Female Reproductive Tract.
Sakaguchi D; Miyado K; Iwamoto T; Okada H; Yoshida K; Kang W; Suzuki M; Yoshida M; Kawano N
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486486
[TBL] [Abstract][Full Text] [Related]
17. Identification of increased amounts of eppin protein complex components in sperm cells of diabetic and obese individuals by difference gel electrophoresis.
Paasch U; Heidenreich F; Pursche T; Kuhlisch E; Kettner K; Grunewald S; Kratzsch J; Dittmar G; Glander HJ; Hoflack B; Kriegel TM
Mol Cell Proteomics; 2011 Aug; 10(8):M110.007187. PubMed ID: 21525168
[TBL] [Abstract][Full Text] [Related]
18. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I.
Robert M; Gibbs BF; Jacobson E; Gagnon C
Biochemistry; 1997 Apr; 36(13):3811-9. PubMed ID: 9092810
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of RSIY-11, a novel seminal peptide derived from semenogelin-1, which acts as a neutral endopeptidase inhibitor modulating sperm motility.
Fritz R; Mukherjee A; Zaghi S; Agalliu I; Jindal S; Tashima AK; Fricker LD; Davies KP
J Assist Reprod Genet; 2019 Sep; 36(9):1891-1900. PubMed ID: 31346917
[TBL] [Abstract][Full Text] [Related]
20. Eppin: an effective target for male contraception.
O'Rand MG; Widgren EE; Wang Z; Richardson RT
Mol Cell Endocrinol; 2006 May; 250(1-2):157-62. PubMed ID: 16423450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]